These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 12673801

  • 1. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M, BroZek I, Wysocka B, Haraldsson K, Sandberg T, Johansson U, Sellberg G, Borg A, Limon J.
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [Abstract] [Full Text] [Related]

  • 2. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
    Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, Limon J.
    Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
    [Abstract] [Full Text] [Related]

  • 3. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E.
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [Abstract] [Full Text] [Related]

  • 4. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.
    Kang HC, Kim IJ, Park JH, Kwon HJ, Won YJ, Heo SC, Lee SY, Kim KH, Shin Y, Noh DY, Yang DH, Choe KJ, Lee BH, King SB, Park JG.
    Hum Mutat; 2002 Sep; 20(3):235. PubMed ID: 12204006
    [Abstract] [Full Text] [Related]

  • 5. BRCA1 and BRCA2 mutations in a South American population.
    Jara L, Ampuero S, Santibáñez E, Seccia L, Rodríguez J, Bustamante M, Martínez V, Catenaccio A, Lay-Son G, Blanco R, Reyes JM.
    Cancer Genet Cytogenet; 2006 Apr 01; 166(1):36-45. PubMed ID: 16616110
    [Abstract] [Full Text] [Related]

  • 6. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
    Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, Chopin S, Methakijvaroon S, Badzioch M, Padungsutt P, Vattanaviboon P, Vattanasapt V, Szabo C, Saunders GF, Goldgar D, Lenoir GM.
    Hum Mutat; 2002 Sep 01; 20(3):230. PubMed ID: 12203997
    [Abstract] [Full Text] [Related]

  • 7. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H.
    Br J Cancer; 2000 Sep 01; 83(6):737-42. PubMed ID: 10952777
    [Abstract] [Full Text] [Related]

  • 8. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.
    Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Tanaka K, Japanese Familial Ovarian Cancer Study Group.
    Clin Cancer Res; 2001 Oct 01; 7(10):3144-50. PubMed ID: 11595708
    [Abstract] [Full Text] [Related]

  • 9. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE, Lüleci G, Ozçelik T, Colak T, Schayek H, Akaydin M, Friedman E.
    Hum Mutat; 2003 Apr 01; 21(4):444-5. PubMed ID: 12655560
    [Abstract] [Full Text] [Related]

  • 10. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
    Hum Mutat; 2000 Dec 01; 16(6):491-501. PubMed ID: 11102978
    [Abstract] [Full Text] [Related]

  • 11. Novel germline BRCA1 and BRCA2 mutations in breast and breast/ovarian cancer families from the Czech Republic.
    Machackova E, Damborsky J, Valik D, Foretova L.
    Hum Mutat; 2001 Dec 01; 18(6):545. PubMed ID: 11748848
    [Abstract] [Full Text] [Related]

  • 12. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K, Machackova E, De Vos M, Mortier G, De Paepe A, Messiaen L.
    Hum Mutat; 1999 Dec 01; 13(3):256. PubMed ID: 10090482
    [Abstract] [Full Text] [Related]

  • 13. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I, Kleibl Z, Stribrna J, Kotlas J, Zimovjanova M, Mateju M, Zikan M, Pohlreich P.
    Breast Cancer Res Treat; 2010 Nov 01; 124(2):337-47. PubMed ID: 20135348
    [Abstract] [Full Text] [Related]

  • 14. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G, Capalbo C, Ristori E, Ricevuto E, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):83-91. PubMed ID: 16847550
    [Abstract] [Full Text] [Related]

  • 15. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E, Zientek H, Jasinska A, Rusin M, Kozlowski P, Sobczak K, Sikorska A, Kwiatkowska E, Gorniak L, Kalinowska E, Utracka-Hutka B, Wloch J, Chmielik E, Krzyzosiak WJ.
    Hum Mutat; 2000 Dec 01; 16(6):482-90. PubMed ID: 11102977
    [Abstract] [Full Text] [Related]

  • 16. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
    Egeli U, Cecener G, Tunca B, Tasdelen I.
    Cancer Invest; 2006 Dec 01; 24(5):484-91. PubMed ID: 16939956
    [Abstract] [Full Text] [Related]

  • 17. Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
    Hartikainen JM, Kataja V, Pirskanen M, Arffman A, Ristonmaa U, Vahteristo P, Ryynänen M, Heinonen S, Kosma VM, Mannermaa A.
    Clin Genet; 2007 Oct 01; 72(4):311-20. PubMed ID: 17850627
    [Abstract] [Full Text] [Related]

  • 18. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK, Saloustros E, Hansen NA, Schluger AE, Kauff ND, Offit K, Robson ME.
    Breast Cancer Res Treat; 2010 Sep 01; 123(2):581-5. PubMed ID: 20221693
    [Abstract] [Full Text] [Related]

  • 19. Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.
    Miramar MD, Calvo MT, Rodriguez A, Antón A, Lorente F, Barrio E, Herrero A, Burriel J, García de Jalón A.
    Breast Cancer Res Treat; 2008 Nov 01; 112(2):353-8. PubMed ID: 18176857
    [Abstract] [Full Text] [Related]

  • 20. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
    Clin Cancer Res; 2002 Dec 01; 8(12):3776-81. PubMed ID: 12473589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.